To explore the efficacy and complications of endoscopic subcutaneous glandectomy and axillary lymph node dissection combined with prosthesis implantation in the treatment of breast cancer.

The clinical data of 79 patients with breast cancer treated by surgery from February 2021 to February 2023 were retrospectively analyzed, and divided into observation group (n=42 cases, endoscopic subcutaneous glandectomy, axillary lymph node dissection and prosthesis implantation) and control group (n=37 cases, traditional modified radical surgery) according to different operation methods. SPSS 22.0 software was used for statistical analysis. The overall good and good rate and complication rate were tested by χ² test. The treatment effect was tested by Rank Sum test. Perioperative relevant indexes were expressed as () and independent sample t test was used. P < 0.05 was considered to be statistically significant.

The operation time of observation group was longer than that of control group (P < 0.05), but the length of hospital stay, extubation time and blood loss were less than that of control group (P < 0.05). After 6 months of treatment, the total good and good rate of observation group was higher than that of control group (P < 0.05). The total incidence of postoperative complications in observation group (4.8%) was lower than that in control group (21.6%) (P < 0.05).

Endoscopic subcutaneous glandectomy and axillary lymph node dissection combined with prosthesis implantation are effective in the treatment of breast cancer, with faster recovery, less trauma and higher safety.